The genetics of inflammatory bowel disease: Diagnostic and therapeutic implications

World Journal of Pediatrics

Volumn 6, Issue 3, 2010, Pages 203-209

  Cuffari, Carmen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 mercaptopurine metabolites; genetics; inflammatory bowel diseases; pharmacogenomics

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; INTERLEUKIN 23 RECEPTOR; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ADAPTIVE IMMUNITY; AUTOPHAGY; B LYMPHOCYTE; BONE MARROW SUPPRESSION; CHROMOSOME 16; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; CROHN DISEASE; CYTOTOXICITY; DNA POLYMORPHISM; DRUG METABOLISM; ENTERITIS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; ILEUM; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LEUKOCYTE ADHESION DEFICIENCY; MEDLINE; OCULAR ALBINISM; PHARMACOGENOMICS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; ULCERATIVE COLITIS;

AZATHIOPRINE; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-23; METHYLTRANSFERASES; NOD2 SIGNALING ADAPTOR PROTEIN; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 77956027655     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-010-0219-7     Document Type: Review

References (60)

1. Mendeloff AI, Calkins BM. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease. Philadelphia: Lea & Febiger, 1988: 3-34.
2. A.I. Mendeloff 1980 The epidemiology of Inflammatory Bowel Disease Clin Gastroenterol 9 258
3. J. Satsangi D.P. Jewell W.M. Rosenberg J.I. Bell 1994 Genetics of inflammatory bowel disease Gut 35 696 700 10.1136/gut.35.5.696 1:STN:280:DyaK2c3lvFegtw%3D%3D 8200569
4. H. Yang C. McElree M.P. Roth F. Shanahan S.R. Targan J.I. Rotter 1993 Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews Gut 34 517 524 10.1136/gut.34.4.517 1:STN:280: DyaK3s3lvFCqsQ%3D%3D 8491401
5. N.P. Thompson R. Driscoll R.E. Pounder A.J. Wakefield 1996 Genetics versus environment in inflammatory bowel disease: results of a British twin study BMJ 312 95 96 1:STN:280:DyaK287ktF2huw%3D%3D 8555939
6. J.A. Mcbride M.J. King A.G. Baikie G.P. Crean W. Sircus 1963 Ankylosing spondylitis and chronic inflammatory bowel diseases of the intestines Br Med J 2 483 486 10.1136/bmj.2.5355.483 1:STN:280:DyaF2c%2FgtFartg%3D%3D 14043713
7. W.H. Price 1979 A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome J Med Genet 16 263 266 10.1136/jmg.16.4.263 1:STN:280:DyaL3c%2FivFGltA%3D%3D 490578
8. R.A. Bennett P.H. Rubin D.H. Present 1991 Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease Gastroenterology 100 1638 1643 1:STN:280:DyaK3M3gvFOhtQ%3D%3D 2019369
9. J.P. Hugot P. Laurent-Puig C. Gower-Rousseau J.M. Olson J.C. Lee L. Beaugerie, et al. 1996 Mapping of a susceptibility locus for Crohn's disease on chromosome 16 Nature 379 821 823 10.1038/379821a0 1:CAS:528:DyaK28XhsVWlu7Y%3D 8587604
10. J.D. Ohmen H.Y. Yang K.K. Yamamoto H.Y. Zhao Y. Ma L.G. Bentley, et al. 1996 Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis Hum Mol Genet 5 1679 1683 10.1093/hmg/5.10.1679 1:CAS:528:DyaK28Xmt1antLs%3D 8894707
11. J.H. Cho Y. Fu B. Kirschner S.B. Hanauer 1997 Confirmation of susceptibility locus IBD 1 for Crohn's disease on chromosome 16 Gastroenterology 112 A948
12. J.A. Cavanaugh D.F. Callen S.R. Wilson P.M. Stanford M.E. Sraml M. Gorska, et al. 1998 Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16 Ann Hum Genet 62 291 298 10.1046/j.1469-1809.1998.6240291.x 1:STN:280: DyaK1M7itlKrsA%3D%3D 9924607
13. J. Hampe T. Wienker P. Nurnberg S. Schreiber 2000 Mapping genes for polygenic disorders: considerations for study design in the complex trait in inflammatory bowel disease Hum Hered 50 91 101 10.1159/000022896 1:CAS:528:DC%2BD3cXisVelsg%3D%3D 10799967
14. A. Hofmeister H.L. Neibergs R.M. Pokorny S. Galandiuk 1997 The natural resistance-associated macrophage protein gene is associated with Crohn's disease Surgery 122 173 178 10.1016/S0039-6060(97)90006-4 1:STN:280: DyaK2svjsVagtg%3D%3D 9288120
15. S.R. Brant C.I. Panhuysen J.E. Bailey-Wilson P.M. Rohal S. Lee J. Mann, et al. 2000 Linkage heterogeneity for the IBD 1 locus in Crohn's disease pedigrees by disease onset and severity Gastroenterology 119 1483 1490 10.1053/gast.2000.20245 1:CAS:528:DC%2BD3MXhtlKgug%3D%3D 11113069
16. R.H. Duerr D.A. Neigut 1995 Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup Gastroenterology 108 423 427 10.1016/0016-5085(95)90069-1 1:STN:280: DyaK2M7jslaltA%3D%3D 7835583
17. M.E. Curran K.F. Lau J. Hampe S. Schreiber S. Bridger A.J. Macpherson, et al. 1998 Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosome 12 and 16 Gastroenterology 115 1066 1071 10.1016/S0016-5085(98)70075-7 1:STN:280:DyaK1M%2FhsVWqsw%3D%3D 9797359
18. J. Hampe J. Grebe S. Nikolaus C. Solberg P.J. Croucher S. Mascheretti, et al. 2002 Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study Lancet 359 1661 1665 10.1016/S0140-6736(02)08590-2 1:CAS:528:DC%2BD38XjvVWjs70%3D 12020527
19. S. Lesage H. Zouali J.P. Cézard the EPWG-IBD group J.F. Colombel the EPIMAD group, et al. 2002 CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease Am J Hum Genet 70 845 857 10.1086/339432 1:CAS:528:DC%2BD38XivFClurw%3D 11875755
20. R.S. Blumberg W. Strober 2001 Prospects for research in inflammatory bowel disease JAMA 285 643 647 10.1001/jama.285.5.643 1:CAS:528: DC%2BD3MXhtlamsb8%3D 11176874
21. S. Kugathasan N. Collins K. Maresso R.G. Hoffmann M. Stephens S.L. Werlin, et al. 2004 CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease Clin Gastroenterol Hepatol 2 1003 1009 10.1016/S1542-3565(04)00452-5 1:CAS:528:DC%2BD2cXhtFWqsbfO 15551253
22. M. Chamaillard R. Iacob P. Desreumaux J.F. Colombel 2006 Advances and perspectives in the genetics of inflammatory bowel diseases Clin Gastroenterol Hepatol 4 143 151 10.1016/j.cgh.2005.11.008 1:CAS:528:DC%2BD28Xit1Gqu7k%3D 16469672
23. K.S. Kobayashi M. Chamaillard Y. Ogura O. Henegariu N. Inohara G. Nuñez, et al. 2005 Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 731 734 10.1126/science.1104911 1:CAS:528:DC%2BD2MXpt1Wqtw%3D%3D 15692051
24. J.D. Rioux M.S. Silverberg M.J. Daly A.H. Steinhart R.S. McLeod A.M. Griffiths, et al. 2000 Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci Am J Hum Genet 66 1863 1870 10.1086/302913 1:CAS:528:DC%2BD3cXntV2jurw%3D 10777714
25. F. Friedrichs S. Brescianini V. Annese A. Latiano K. Berger S. Kugathasan, et al. 2006 Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men Hum Genet 119 305 311 10.1007/s00439-006-0133-1 16446977
26. H.P. Török J. Glas L. Tonenchi T. Mussack C. Folwaczny 2004 Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis Clin Immunol 112 85 91 10.1016/j.clim.2004.03.002 15207785
27. E. Cario D.K. Podolsky 2000 Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease Infect Immun 68 7010 7017 10.1128/IAI.68.12.7010- 7017.2000 1:CAS:528:DC%2BD3MXjslCku7w%3D 11083826
28. D. Franchimont S. Vermeire H. El Housni M. Pierik K. Van Steen T. Gustot, et al. 2004 Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis Gut 53 987 992 10.1136/gut.2003.030205 1:CAS:528:DC%2BD2cXlvFemtrY%3D 15194649
29. H.P. Török J. Glas L. Tonenchi G. Bruennler M. Folwaczny C. Folwaczny 2004 Crohn's disease is associated with a toll-like receptor-9 polymorphism Gastroenterology 127 365 366 10.1053/j.gastro.2004.05.051 15236225
30. R.H. Duerr K.D. Taylor S.R. Brant J.D. Rioux M.S. Silverberg M.J. Daly, et al. 2006 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 314 1461 1463 10.1126/science.1135245 1:CAS:528:DC%2BD28Xht1CntrjF 17068223
31. J. Hampe A. Franke P. Rosenstiel A. Till M. Teuber K. Huse, et al. 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 39 207 211 10.1038/ng1954 1:CAS:528:DC%2BD2sXpvFerug%3D%3D 17200669
32. D.K. Bonen J.H. Cho 2003 The genetics of inflammatory bowel disease Gastroenterology 124 521 536 10.1053/gast.2003.50045 1:CAS:528: DC%2BD3sXhsFOgs78%3D 12557156
33. K.N. Lazaridis G.M. Petersen 2005 Genomics, genetic epidemiology, and genomic medicine Clin Gastroenterol Hepatol 3 320 328 10.1016/S1542-3565(05) 00085-6 1:CAS:528:DC%2BD2MXktVSju7c%3D 15822036
34. M. Parkes J.C. Barrett N.J. Prescott M. Tremelling C.A. Anderson S.A. Fisher, et al. 2007 Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility Nat Genet 39 830 832 10.1038/ng2061 1:CAS:528:DC%2BD2sXmvFKlsL4%3D 17554261
35. C.M. Collazo G.S. Yap G.D. Sempowski K.C. Lusby L. Tessarollo G.F. Woude, et al. 2001 Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection J Exp Med 194 181 188 10.1084/jem.194.2.181 1:CAS:528: DC%2BD3MXlsVCksbY%3D 11457893
36. F. Shanahan J. O'Mahony 2005 The mycobacteria story in Crohn's disease Am J Gastroenterol 100 1537 1538 10.1111/j.1572-0241.2005.50358.x 15984977
37. Gurbindo C, Seidman EG. Gastrointestinal manifestations of primary immunodeficiency disorders. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins B, eds. Pediatric Gastrointestinal Disease Pathophysiology, Diagnosis, Management, 2nd ed. St. Louis: Mosby CV, 1996: 585-605.
38. I.D. D'Agata T. Vanounou E. Seidman 1996 Mesalamine in pediatric inflammatory bowel disease: a 10-year experience Inflamm Bowel Dis 2 229 235 10.1002/ibd.3780020402
39. S. Shivananda A.S. Peña M. Nap I.T. Weterman J.F. Mayberry E.J. Ruitenberg, et al. 1987 Epidemiology of Crohn's disease in Regio Leiden, The Netherlands. A population study from 1979 to 1983 Gastroenterology 93 966 974 1:STN:280:DyaL1c%2FgsFKktQ%3D%3D 3498661
40. Seidman EG. Inflammatory Bowel disease. In: Roy CC, Silverman A, Alagille A, eds. Clinical Pediatric Gastroenterology, 4th ed. Mosby: Philadelphia, 1993.
41. A. Ekbom H.O. Adami C.G. Helmick A. Jonzon M.M. Zack 1990 Perinatal risk factors for inflammatory bowel disease: a casecontrol study Am J Epidemiol 132 1111 1119 1:STN:280:DyaK3M%2Fot1OrtA%3D%3D 2260543
42. A.J. Wakefield A. Ekbom A.P. Dhillon R.M. Pittilo R.E. Pounder 1995 Crohn's disease: pathogenesis and persistent measles virus infection Gastroenterology 108 911 916 10.1016/0016-5085(95)90467-0 1:STN:280: DyaK2M7otVKhsQ%3D%3D 7875495
43. A. Ekbom A.J. Wakefield M. Zack H.O. Adami 1994 Perinatal measles infection and subsequent Crohn's disease Lancet 344 508 510 10.1016/S0140- 6736(94)91898-8 1:STN:280:DyaK2czjsFCmtA%3D%3D 7914614
44. A.J. Wakefield R.M. Pittilo R. Sim S.L. Cosby J.R. Stephenson A.P. Dhillon, et al. 1993 Evidence of persistent measles virus infection in Crohn's disease J Med Virol 39 345 353 10.1002/jmv.1890390415 1:STN:280: DyaK3s3mtVChtQ%3D%3D 8492105
45. J. Lewin A.P. Dhillon R. Sim G. Mazure R.E. Pounder A.J. Wakefield 1995 Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy Gut 36 564 569 10.1136/gut.36.4.564 1:STN:280: DyaK2M3lsFOiug%3D%3D 7737565
46. A. Ekbom A.J. Wakefield M. Zack H.O. Adami 1994 Perinatal measles infection and subsequent Crohn's disease Lancet 344 508 510 10.1016/S0140- 6736(94)91898-8 1:STN:280:DyaK2czjsFCmtA%3D%3D 7914614
47. L. Lennard 1992 The clinical pharmacology of 6-mercaptopurine Eur J Clin Pharmacol 43 329 339 10.1007/BF02220605 1:CAS:528:DyaK3sXptg%3D%3D 1451710
48. G.B. Elion 1993 The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine Ann N Y Acad Sci 685 401 407 10.1111/j.1749-6632. 1993.tb35897.x 1:CAS:528:DyaK3sXlslegu70%3D
49. E.C. Van Os B.J. Zins W.J. Sandborn D.C. Mays W.J. Tremaine D.W. Mahoney, et al. 1996 Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration Gut 39 63 68 10.1136/gut.39.1.63 8881811
50. L. Lennard J.S. Lilleyman 1989 Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia J Clin Oncol 7 1816 1823 1:STN:280:DyaK3c%2FmtlKmug%3D%3D 2585022
51. W.E. Evans M. Horner Y.Q. Chu D. Kalwinsky W.M. Roberts 1991 Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia J Pediatr 119 985 989 10.1016/S0022-3476(05)83063-X 1:STN:280:DyaK38%2FntFygsQ%3D%3D 1960624
52. C. Cuffari Y. Théorêt S. Latour G. Seidman 1996 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity Gut 39 401 406 10.1136/gut.39.3.401 1:STN:280:DyaK2s7gs1yqtQ%3D%3D 8949645
53. M.C. Dubinsky S. Lamothe H.Y. Yang S.R. Targan D. Sinnett Y. Théorêt, et al. 2000 Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease Gastroenterology 118 705 713 10.1016/S0016-5085(00)70140-5 1:CAS:528:DC%2BD3cXis1ens7w%3D 10734022
54. T. Stevens J.P. Achkar K. Easley A. Brzezinski B. Lashner 2004 Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease Aliment Pharmacol Ther 20 601 606 10.1111/j.1365-2036.2004.02154.x 1:CAS:528:DC%2BD2cXovVylt7g%3D 15352907
55. C. Cuffari T. Dassopoulos L. Turnbough R.E. Thompson T.M. Bayless 2004 Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease Clin Gastroenterol Hepatol 2 410 417 10.1016/S1542-3565(04)00127-2 1:CAS:528:DC%2BD2cXkvFGrsL4%3D 15118980
56. C. Cuffari S. Hunt T. Bayless 2001 Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease Gut 48 642 646 10.1136/gut.48.5.642 1:CAS:528:DC%2BD3MXjvVansL8%3D 11302961
57. D.H. Present S.J. Meltzer M.P. Krumholz A. Wolke B.I. Korelitz 1989 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity Ann Intern Med 111 641 649 1:STN:280:DyaK3c%2FisVKqsQ%3D%3D 2802419
58. B.S. Kirschner 1998 Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Gastroenterology 115 813 821 10.1016/S0016-5085(98)70251-3 1:CAS:528:DyaK1cXmvVektr0%3D 9753482
59. A.J. Black H.L. McLeod H.A. Capell R.H. Powrie L.K. Matowe S.C. Pritchard, et al. 1998 Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine Ann Intern Med 129 716 718 1:CAS:528:DyaK1cXnsFCruro%3D 9841604
60. J. Bo H. Schrøder J. Kristinsson B. Madsen C. Szumlanski R. Weinshilboum, et al. 1999 Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism Cancer 86 1080 1086 10.1002/(SICI)1097-0142(19990915)86:6<1080::AID-CNCR26>3.0.CO;2-5 1:STN:280:DyaK1MvitlKjtA%3D%3D 10491537